A detailed history of Janus Henderson Group PLC transactions in Neogenomics Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 6,603,180 shares of NEO stock, worth $109 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
6,603,180
Previous 6,619,336 0.24%
Holding current value
$109 Million
Previous $91.8 Million 6.08%
% of portfolio
0.05%
Previous 0.05%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$13.4 - $17.73 $216,490 - $286,445
-16,156 Reduced 0.24%
6,603,180 $97.4 Million
Q2 2024

Aug 14, 2024

BUY
$13.01 - $15.77 $4.4 Million - $5.34 Million
338,470 Added 5.39%
6,619,336 $91.8 Million
Q1 2024

May 15, 2024

SELL
$14.06 - $16.79 $952,522 - $1.14 Million
-67,747 Reduced 1.07%
6,280,866 $98.7 Million
Q4 2023

Feb 14, 2024

SELL
$11.67 - $20.73 $9.64 Million - $17.1 Million
-825,814 Reduced 11.51%
6,348,613 $103 Million
Q3 2023

Nov 14, 2023

SELL
$12.15 - $17.85 $5.04 Million - $7.41 Million
-415,060 Reduced 5.47%
7,174,427 $88.2 Million
Q2 2023

Aug 14, 2023

BUY
$14.1 - $19.83 $2.33 Million - $3.27 Million
165,135 Added 2.22%
7,589,487 $122 Million
Q1 2023

May 15, 2023

BUY
$9.09 - $19.45 $11.8 Million - $25.3 Million
1,298,581 Added 21.2%
7,424,352 $129 Million
Q4 2022

Feb 14, 2023

BUY
$6.45 - $12.07 $1.06 Million - $1.99 Million
164,627 Added 2.76%
6,125,771 $56.6 Million
Q3 2022

Nov 14, 2022

BUY
$7.86 - $12.91 $38.6 Million - $63.5 Million
4,915,452 Added 470.07%
5,961,144 $51.3 Million
Q2 2022

Aug 15, 2022

SELL
$7.06 - $13.97 $22.9 Million - $45.3 Million
-3,239,416 Reduced 75.6%
1,045,692 $8.52 Million
Q1 2022

May 16, 2022

SELL
$12.15 - $35.28 $1.25 Million - $3.63 Million
-103,011 Reduced 2.35%
4,285,108 $52.1 Million
Q4 2021

Feb 14, 2022

BUY
$30.49 - $48.49 $476,345 - $757,559
15,623 Added 0.36%
4,388,119 $150 Million
Q3 2021

Nov 16, 2021

SELL
$41.66 - $52.52 $2.28 Million - $2.88 Million
-54,742 Reduced 1.24%
4,372,496 $211 Million
Q2 2021

Aug 16, 2021

BUY
$36.62 - $51.69 $11.8 Million - $16.7 Million
323,454 Added 7.88%
4,427,238 $200 Million
Q1 2021

May 17, 2021

BUY
$41.56 - $59.88 $57.6 Million - $83 Million
1,386,761 Added 51.04%
4,103,784 $198 Million
Q4 2020

Feb 16, 2021

BUY
$36.08 - $56.47 $1.33 Million - $2.09 Million
36,992 Added 1.38%
2,717,023 $146 Million
Q3 2020

Nov 16, 2020

SELL
$33.26 - $40.48 $2.03 Million - $2.47 Million
-60,939 Reduced 2.22%
2,680,031 $98.9 Million
Q2 2020

Aug 14, 2020

SELL
$24.21 - $31.02 $1.29 Million - $1.65 Million
-53,299 Reduced 1.91%
2,740,970 $84.9 Million
Q1 2020

May 14, 2020

SELL
$20.5 - $34.53 $13.9 Million - $23.4 Million
-677,771 Reduced 19.52%
2,794,269 $77.2 Million
Q4 2019

Feb 18, 2020

SELL
$18.96 - $29.84 $3.4 Million - $5.35 Million
-179,341 Reduced 4.91%
3,472,040 $102 Million
Q3 2019

Nov 14, 2019

SELL
$19.12 - $26.24 $6.54 Million - $8.97 Million
-341,825 Reduced 8.56%
3,651,381 $69.8 Million
Q2 2019

Jul 31, 2019

SELL
$19.57 - $24.1 $21.7 Million - $26.7 Million
-1,107,082 Reduced 21.71%
3,993,206 $87.6 Million
Q1 2019

Apr 30, 2019

SELL
$12.14 - $20.46 $9.57 Million - $16.1 Million
-788,379 Reduced 13.39%
5,100,288 $104 Million
Q4 2018

Feb 06, 2019

SELL
$11.24 - $18.5 $2.43 Million - $3.99 Million
-215,808 Reduced 3.54%
5,888,667 $74.3 Million
Q3 2018

Nov 09, 2018

SELL
$12.5 - $15.38 $671,625 - $826,367
-53,730 Reduced 0.87%
6,104,475 $93.7 Million
Q2 2018

Aug 10, 2018

SELL
$7.99 - $14.05 $542,592 - $954,121
-67,909 Reduced 1.09%
6,158,205 $80.7 Million
Q1 2018

May 14, 2018

BUY
$7.23 - $8.76 $4.71 Million - $5.71 Million
652,002 Added 11.7%
6,226,114 $50.8 Million
Q4 2017

Feb 09, 2018

BUY
$8.02 - $11.18 $16.9 Million - $23.6 Million
2,109,457 Added 60.89%
5,574,112 $49.4 Million
Q3 2017

Nov 14, 2017

BUY
$9.11 - $11.26 $10.6 Million - $13.1 Million
1,159,888 Added 50.33%
3,464,655 $0
Q2 2017

Aug 17, 2017

BUY
N/A
2,304,767
2,304,767 $20.7 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.08B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.